In line with current hypotheses from different in vivo imaging modalities [26, 58, 65, 66], Aβ deposition in the early phases of AD may initially cause a phase of hyperactivity, which could in turn enhance or stimulate regional tau deposition. The gene discussed is MAPT; the disease is Alzheimer disease.